October is Breast Cancer Awareness Month, a global annual campaign that unites organizations around the world to raise awareness for breast cancer, and highlights the importance of breast cancer education and research.
Breast cancer is the second leading cause of cancer death in American women. About 12%, or 1 in 8, women in the US will develop breast cancer over the course of her lifetime. Worldwide, breast cancer is the most common cancer in women.
Many government agencies and non-profit organizations, such as NCI, CDC, and American Cancer Society, have devoted resources and funding to support research studies and encourage screening for early detection. For example, the American Cancer Society has provided $67 million of funding for breast cancer as of August 2019.
Breast cancer research requires high quality research tools. Explore Boster's catalog to find antibodies, kits, and other reagents you may need for your research. In addition, click below to find out more about breast cancer, the international campaign, and ongoing research and funding.
Boster takes great measures to ensure product quality and to provide our customers with comprehensive data upfront. Our antibodies are validated using WB, IHC, and flow cytometry against a panel of over 250 tissues and un-transfected cell lines to ensure high affinity and crystal-clear IHC stains. In addition, we also validate our antibodies in a quantitative fashion by testing them on known quantities of recombinant proteins so that you know what to expect (e.g. if there is 1ng, 2.5ng or 5ng of the target protein in the sample). Every product is covered by the Boster Quality Guarantee, click below to learn more.